100 Days Mission
The 100 Days Mission (100DM) implementation is supported by the International Pandemic Preparedness Secretariat and aims to accelerate the development of safe, effective and affordable diagnostics, therapeutics and vaccines (DTVs) within the first 100 days of an emerging health threat. The Pandemic PACT Grant Tracker is monitoring investments aligned with the 100DM objectives as shown by the visualisations below. Pandemic PACT is also a data source for the G-Finder project (which feeds the 100DM Scorecard) developed by Impact Global Health (IGH) in partnership with IPPS, with whom we are collaborating to map a comprehensive landscape of investments, track progress and identify persistent gaps.
Grants visualised on this page cover those with an explicit focus on relevant pre-clinical and clinical research to the 100DM. We also show capacity strengthening grants on various aspects of individual, institutional and systemic capacity strengthening related to DTV research and grants on data management and data sharing which include those exploring processes on collecting, organising, storing, and maintaining data on DTV research.
Research Grants
Explore how funding is allocated across Clinical and Preclinical Research grants
Pathogen
Charts showing distribution of research grants by pathogen families and pathogens
Clinical Trials
Explore how funding is allocated across various Trial Phases
Study Populations
Charts showing the distribution of Study Populations across Clinical Research Grants
Geographical Distribution
Charts showing research locations and location of Capacity Strengthening Grants
Implementation & Access
Charts showing research on implementation of clinical research and access to Vaccines, Therapeutics and Vaccines
Distribution Of Research Grants By Research Area
Show Data Management & Data Sharing Grants
Number of Grants
Known Financial Commitments (USD)
0
$0.00
0
$0.00
0
$0.00
0
$0.00
Please note: Grants may fall under more than one research category, and funding amounts are included only when they have been published by the funder. Grants on data management and data sharing explore processes on collecting, organising, storing, and maintaining data on DTV research.
Distribution of research grants by pathogen families and pathogen
Grants may fall under more than one family or pathogen
| Clinical characterisation and management | Therapeutics | Diagnostics | Vaccines | Total | |
|---|---|---|---|---|---|
| Arenaviridae | 0 | 0 | 0 | 0 | 0 |
| Coronaviridae | 0 | 0 | 0 | 0 | 0 |
| Enterobacteriaceae | 0 | 0 | 0 | 0 | 0 |
| Filoviridae | 0 | 0 | 0 | 0 | 0 |
| Flaviviridae | 0 | 0 | 0 | 0 | 0 |
| Hantaviridae | 0 | 0 | 0 | 0 | 0 |
| Nairoviridae | 0 | 0 | 0 | 0 | 0 |
| Orthomyxoviridae | 0 | 0 | 0 | 0 | 0 |
| Paramyxoviridae | 0 | 0 | 0 | 0 | 0 |
| Phenuiviridae | 0 | 0 | 0 | 0 | 0 |
| Poxviridae | 0 | 0 | 0 | 0 | 0 |
| Togaviridae | 0 | 0 | 0 | 0 | 0 |
| Unknown | 0 | 0 | 0 | 0 | 0 |
| Vibrionaceae | 0 | 0 | 0 | 0 | 0 |
| Yersiniaceae | 0 | 0 | 0 | 0 | 0 |
Distribution of Clinical Research Grants by Clinical Trial Phases
Number of grants
0
0
0
0
0
Known Financial Commitments (USD)
$0.00
$0.00
$0.00
$0.00
$0.00
Please note: Grants may fall under more than one research category, and funding amounts are included only when they have been published by the funder.
Distribution of Research Grants by Study Populations
Hide Unspecified
Age Groups
0
Vulnerable Populations
0
Rurality
0
Occupational Groups
0
Ethnicity
0
Please note: Grants may include more than one study population. Study populations involved in research are as mentioned in grant information.
Geographical Distribution Of Research Grants And Capacity Strengthening Grants
The information on the research location was collected where available from the grant application, and can be different to the location of research institution. Click on a country to see country-specific grant information (including co-funded grants).
Show capacity strengthening grants
Number of Joint Grants
No data available due to applied filters.
Please note: Locations of grants indicating capacity strengthening as an objective or involving research on research capacity strengthening also shown.